About
Advisor to Lightstone Ventures and President, CEO and co-founder of Tallac Therapeutics. Hong previously served as Chief Scientific Officer at ALX Oncology leading clinical advancement and held leadership positions at Pfizer and Wyeth Research across therapeutic areas.
Colleagues at Lightstone Ventures
Brendan Kelly
Principal at Lightstone Ventures
Brendan Kelly, Ph.D.
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures